received April 5, 1999, revised May 12, 1999, accepted May 19, 1999. We prove that the number of permutations which avoid 132-patterns and have exactly one 123-pattern, equals (n 2)2n 3 , for n 3. We then give a bijection onto the set of permutations which avoid 123-patterns and have exactly one 132-pattern. Finally, we show that the number of permutations which contain exactly one 123-pattern ...

Background: Studies of lymphatic vessels were limited by the lack of specific markers. Recently, they have become possible due to the release of new D2-40 antibody, a selective marker for lymphatic endothelium. The aim of our study was to compare neoplastic invasion in lymphatic and blood vessels detected in hematoxylin and eosin (H&E) and immunohistochemistry-stained sections. Methodology: A t...

If H is a 3-graph, then ex(n;H) denotes the maximum number of edges in a 3-graph on n vertices containing no sub-3-graph isomorphic to H. Let S(n) denote the 3-graph on n vertices obtained by partitioning the vertex set into parts of sizes ⌈ n 2 ⌉ and ⌊ n 2 ⌋ and taking as edges all triples that intersect both parts. Let s(n) denote the number of edges in S(n). Let F (3, 3) denote the 3-graph {...

PURPOSE To determine the maximum-tolerated dose, toxicity profile, and pharmacokinetics of a fixed dose of paclitaxel followed by increasing doses of carboplatin, given weekly to patients with advanced esophageal or gastric junction cancer. EXPERIMENTAL DESIGN Paclitaxel was administered on day 1 as a 1-h infusion at a fixed dose of 100 mg/m(2) followed by a 1-h infusion of carboplatin target...

#P [20]. (2× 2 ·G): 2 [160]. 1 [174]. 12 [190]. 13A [321]. 2 [154, 269, 216, 117, 317, 146, 172, 6, 51]. 3 [216, 166]. 30 [11]. 4 [124]. 47: 23 [341]. 5 [332]. 6 [276, 142]. 6560 [54]. 7 [354]. 8 [267]. F4(q) [143, 161]. a − 2 = c [211]. a − 2b = c [211]. An [85]. B [73]. C [264]. C3,4 [122]. d [198]. E6 [123]. E7(2) [306]. E8 [123, 147]. ` [295]. F16 [126]. Fi24 [132]. GF(2) [104]. GF(p) [369]...

!" # $ % & ' ( ) * '!,+ ! -+ !. / $ 0 1+. 2 3 54 +6 $ ' ) % 3 7 / . * '! 8 9 :; . @ " ) % A B C < ?+?D ) !E $ . 6 . 3 "9GFH I4 J K 4 L B * M R A9*:; A </ W R & $ < I <" )4/ )<H $ ) WL'!5 * 8 ...

UNLABELLED (123)I-ADAM (2-([2-([dimethylamino]methyl)phenyl]thio)-5-(123)I-iodophenylamine) has been recently proposed as a new serotonin transporter (SERT) ligand for SPECT. The objective of this study was to characterize (123)I-ADAM in healthy volunteers. (123)I-ADAM distribution in the normal brain, pseudoequilibrium interval after a single injection, normal specific uptake values, and long-...